MedPath

Pharmalundensis AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)

Phase 1
Conditions
Chronic Fatigue Syndrome
Interventions
Drug: IodoCarb (r)
Other: Placebo
First Posted Date
2013-02-15
Last Posted Date
2013-02-15
Lead Sponsor
PharmaLundensis AB
Target Recruit Count
40
Registration Number
NCT01793415
Locations
🇸🇪

Probare i Lund AB, Lund, Sweden

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal

Phase 2
Completed
Conditions
Chronic Obstructive Lung Disease
Interventions
Drug: Iodinated Active Charcoal (IodoCarb)
First Posted Date
2011-07-27
Last Posted Date
2013-11-15
Lead Sponsor
PharmaLundensis AB
Target Recruit Count
40
Registration Number
NCT01404000
Locations
🇸🇪

Dept of Respiratory Medcine & Allergology, Skane University Hospital, Lund, Sweden

© Copyright 2025. All Rights Reserved by MedPath